STOCK TITAN
  1. Home
  2. Sec-filings
  3. BCTXZ
  4. [8-K] BriaCell Therapeutics Corp. Warrant Reports Material Event

[8-K] BriaCell Therapeutics Corp. Warrant Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BCTXZ logo
Briacell Therapeutics Corp

NASDAQ:BCTXZ

BCTXZ Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

BCTXZ Latest News

Aug 26, 2025
BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
Aug 25, 2025
BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer
Aug 21, 2025
BriaCell Announces Proposed Effective Date of Share Consolidation
Aug 13, 2025
BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer
Aug 5, 2025
BriaCell Announces Proposed Effective Date of Share Consolidation

BCTXZ Latest SEC Filings

Jul 28, 2025
[SCHEDULE 13G] BriaCell Therapeutics Corp. Warrant SEC Filing
Jul 22, 2025
[SCHEDULE 13G] BriaCell Therapeutics Corp. Warrant SEC Filing
Jul 21, 2025
[SCHEDULE 13G/A] BriaCell Therapeutics Corp. Warrant SEC Filing
Jul 15, 2025
[424B4] BriaCell Therapeutics Corp. Warrant Prospectus Filed Pursuant to Rule 424(b)(4)
Jul 10, 2025
[S-1/A] BriaCell Therapeutics Corp. Warrant Amends IPO Registration Statement

BCTXZ Stock Data

2.33M
Biotechnology
Pharmaceutical Preparations
Link
Canada
WEST VANCOUVER